Gilead Sciences Inc.’s stock jumped early Thursday after the company said its experimental injection for HIV prevention was found 100% effective in a late-stage trial.
It is no secret that small-cap stocks have struggled this year — and last year, too. In fact, they have underperformed their large-cap peers for more than a decade now.
A pullback and consolidation could be on the way for stocks this summer, with a big clue from bitcoin, say strategists at Stifel.
Underestimating Squibb — or any senior — is a big mistake.
The Philadelphia Federal Reserve said Thursday its gauge of regional business activity inched down to 1.3 in June from 4.5 in the prior month.
Tesla and SpaceX co-founder reveals role in xAI supercomputer for Dell and Super Micro after mentioning Nvidia chips.
Construction on new U.S. homes fell 5.5% in May, the Commerce Department said Thursday.
Index funds in the spotlight, a big tech ETF dumps some Apple shares, and two fund managers tell how they’re beating the market
